rxstat › Shortages › Aprepitant

Aprepitant shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Aprepitant products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 2
Reports on file
3

Reports by product

To be discontinued
EMEND
125MG · CAPSULE · MERCK CANADA INC
DIN 02298805
To be discontinued
EMEND
80MG · CAPSULE · MERCK CANADA INC
DIN 02298791
Avoided
EMEND
80MG · CAPSULE · MERCK CANADA INC
DIN 02298791 · ended Jun 23, 2022 · Delay in shipping of the drug.

What's happening

One or more Aprepitant products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Aprepitant is classified under “ANTIEMETICS AND ANTINAUSEANTS” (ATC A04AD).

Recent changes

Common questions

When will Aprepitant be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Aprepitant in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiemetics and antinauseants)

Widespread shortageGranisetron2 of 2 reported products affected · est. return Jul 24, 2026Partial shortageOndansetron11 of 54 reported products affected · est. return Oct 30, 2026Partial shortagePalonosetron1 of 2 reported products affectedDiscontinuedAprepitant Aprepitant0 of 1 reported products affectedShortage anticipatedFosaprepitant0 of 1 reported products affectedNo current shortageNabilone

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.